TCTMD
@TCTMD
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at https://t.co/9j3KOiiahQ
14-05-2009 17:36:57
17,2K Tweets
26,1K Followers
6,6K Following
“Several patients have not been able to access the 1-mg subcutaneous semaglutide pens since around December,” along with shortages of dulaglutide and tirzepatide as well, explains Harriette Van Spall, MD MPH for TCTMD. More on the shortage and potential alternatives here: tctmd.com/news/injectabl…
